# Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)

> **NCT00779532** · PHASE1 · COMPLETED · sponsor: **Organon and Co** · enrollment: 189 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** NOMAC-E2 (Org 10486-0 + Org 2317)
- **DRUG:** Moxifloxacin placebo
- **DRUG:** NOMAC-E2 placebo

## Key facts

- **NCT ID:** NCT00779532
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779532, "Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00779532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*